XML 149 R125.htm IDEA: XBRL DOCUMENT v3.24.0.1
REVISED 2023 QUARTERLY FINANCIAL INFORMATION (UNAUDITED) - Results of Operations (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Condensed Financial Information Disclosure [Line Items]                          
Revenue $ 963 $ 978 $ 967 $ 922 $ 966 $ 960 $ 950 $ 917 $ 1,889 $ 2,867 $ 3,830 $ 3,793 $ 3,692
Selling, general and administrative expenses   162 167 156         323 486 740 695 704
Research and development expenses   38 42 49         91 129 185 147 195
Total operating expenses   907 900 893         1,793 2,700 3,793 3,657 3,666
Income (loss) from operations (130) 71 67 29 58 55 24 (1) 96 167 37 136 26
Loss on extinguishment of debt   0 0 0         0 0 (46) 0 (42)
Interest expense   (83) (91) (83)         (174) (257) (294) (285) (238)
Other income (expense), net   (25) (9) (4)         (13) (38) (79) 18 (13)
Income (loss) from continuing operations before income taxes   (37) (33) (58)         (91) (128) (382) (131) (267)
Income tax expense (benefit)   185 8 7         15 200 204 72 70
Income from continuing operations (258) (222) (41) (65) (12) (38) (57) (96) (106) (328) (586) (203) (337)
Income (loss) from discontinued operations, net of tax (61) 94 57 73 (6) 107 100 61 130 224 163 262 435
Net income (loss) (319) (128) 16 8 (18) 69 43 (35) 24 (104) (423) 59 98
Net income (loss) attributable to noncontrolling interests   0 0 0         0 0 0 (1) 1
Net income (loss) attributable to noncontrolling interests   1 (1) 1         0 1 0 (1) 1
Net income (loss)   (129) 17 7         24 (105) (423) 60 97
Net income (loss) from continuing operations attributable to NCR Voyix (GAAP)   (222) (41) (65)         (106) (328) (586) (203) (337)
Series A convertible preferred stock dividends   (4) (4) (4)         (8) (12) (16) (16) (16)
income (loss) from continuing operations attributable to common stockholders   (226) (45) (69)         (114) (340) (602) (219) (353)
Income (loss) from discontinued operations, net of tax   93 58 72         130 223 163 263 434
Total reclassifications, net of tax $ (322) $ (133) $ 13 $ 3 $ (20) $ 65 $ 37 $ (38) $ 16 $ (117) $ (439) $ 44 $ 81
Continuing operations. basic (in dollars per share) $ (1.85) $ (1.60) $ (0.32) $ (0.49) $ (0.12) $ (0.31) $ (0.46) $ (0.72) $ (0.81) $ (2.41) $ (4.28) $ (1.60) $ (2.69)
Discontinued operations, basic (in dollars per share) (0.43) 0.66 0.41 0.51 (0.03) 0.78 0.73 0.44 0.92 1.58      
Net income attributable to common shareholders, basic (in dollars per share) (2.28) (0.94) 0.09 0.02 (0.15) 0.47 0.27 (0.28) 0.11 (0.83) (3.12) 0.32 0.62
Diluted (in dollars per share) (1.85) (1.60) (0.32) (0.49) (0.12) (0.31) (0.46) (0.72) (0.81) (2.41) (4.28) (1.60) (2.69)
Discontinued operations, diluted (in dollars per share)   0.66 0.41 0.51         0.92 1.58      
Diluted (in dollars per share) $ (2.28) $ (0.94) $ 0.09 $ 0.02 $ (0.15) $ 0.47 $ 0.27 $ (0.28) $ 0.11 $ (0.83) $ (3.12) $ 0.32 $ 0.62
As reported                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   $ 2,017 $ 1,986 $ 1,891         $ 3,877 $ 5,894      
Selling, general and administrative expenses   331 333 292         625 956      
Research and development expenses   54 57 64         121 175      
Total operating expenses   1,775 1,838 1,781         3,619 5,394      
Income (loss) from operations   242 148 110         258 500      
Loss on extinguishment of debt   0 0 0         0 0      
Interest expense   (85) (91) (83)         (174) (259)      
Other income (expense), net   (44) (8) (3)         (11) (55)      
Income (loss) from continuing operations before income taxes   113 49 24         73 186      
Income tax expense (benefit)   236 30 14         44 280      
Income from continuing operations   (123) 19 10         29 (94)      
Income (loss) from discontinued operations, net of tax   0 (1) 0         (1) (1)      
Net income (loss)   (123) 18 10         28 (95)      
Net income (loss) attributable to noncontrolling interests   1 (1) 1         0 1      
Net income (loss) attributable to noncontrolling interests   0 0 0         0 0      
Net income (loss)   (124) 19 9         28 (96)      
Net income (loss) from continuing operations attributable to NCR Voyix (GAAP)   (124) 20 9         29 (95)      
Series A convertible preferred stock dividends   (4) (4) (4)         (8) (12)      
income (loss) from continuing operations attributable to common stockholders   (128) 16 5         21 (107)      
Income (loss) from discontinued operations, net of tax   0 (1) 0         (1) (1)      
Total reclassifications, net of tax   $ (128) $ 15 $ 5         $ 20 $ (108)      
Continuing operations. basic (in dollars per share)   $ (0.91) $ 0.11 $ 0.04         $ 0.15 $ (0.76)      
Discontinued operations, basic (in dollars per share)   0 (0.01) 0         (0.01) (0.01)      
Net income attributable to common shareholders, basic (in dollars per share)   (0.91) 0.11 0.04         0.14 (0.77)      
Diluted (in dollars per share)   (0.91) 0.11 0.04         0.15 (0.76)      
Discontinued operations, diluted (in dollars per share)   0 (0.01) 0         (0.01) (0.01)      
Diluted (in dollars per share)   $ (0.91) $ 0.11 $ 0.04         $ 0.14 $ (0.77)      
Revision of Prior Period, Adjustment                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   $ 0 $ 0 $ 0         $ 0 $ 0      
Selling, general and administrative expenses   6 3 2         5 11      
Research and development expenses   0 0 0         0 0      
Total operating expenses   7 3 2         5 12      
Income (loss) from operations   (7) (3) (2)         (5) (12)      
Loss on extinguishment of debt   0 0 0         0 0      
Interest expense   0 0 0         0 0      
Other income (expense), net   0 0 0         0 0      
Income (loss) from continuing operations before income taxes   (7) (3) (2)         (5) (12)      
Income tax expense (benefit)   (2) (1) 0         (1) (3)      
Income from continuing operations   (5) (2) (2)         (4) (9)      
Income (loss) from discontinued operations, net of tax   0 0 0         0 0      
Net income (loss)   (5) (2) (2)         (4) (9)      
Net income (loss) attributable to noncontrolling interests   0 0 0         0 0      
Net income (loss) attributable to noncontrolling interests   0 0 0         0 0      
Net income (loss)   (5) (2) (2)         (4) (9)      
Discontinued Operations, Disposed of by Means Other than Sale, Spinoff | Spin-Off of Atleos                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   1,039 1,019 969         1,988 3,027      
Selling, general and administrative expenses   175 169 138         307 481      
Research and development expenses   16 15 15         30 46      
Total operating expenses   875 941 890         1,831 2,706      
Income (loss) from operations   164 78 79         157 321      
Loss on extinguishment of debt   0 0 0         0 0      
Interest expense   (2) 0 0         0 (2)      
Other income (expense), net   (19) 1 1         2 (17)      
Income (loss) from continuing operations before income taxes   143 79 80         159 302      
Income tax expense (benefit)   49 21 7         28 77      
Income from continuing operations   94 58 73         131 225      
Income (loss) from discontinued operations, net of tax   (94) (58) (73)         (131) (225) $ 213 $ 266 $ 435
Net income (loss)   0 0 0         0 0      
Net income (loss) attributable to noncontrolling interests   1 (1) 1         0 1      
Net income (loss) attributable to noncontrolling interests   (1) 1 (1)         0 (1) 0 (1) 1
Net income (loss)   0 0 0         0 0      
Income (loss) from discontinued operations, net of tax                     213 267 434
Product                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   318 317 292         609 927 1,239 1,274 1,176
Cost of products   269 273 269         542 811 1,110 1,151 1,032
Product | As reported                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   560 576 521         1,097 1,657      
Cost of products   465 478 456         934 1,399      
Product | Revision of Prior Period, Adjustment                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   0 0 0         0 0      
Cost of products   0 0 0         0 0      
Product | Discontinued Operations, Disposed of by Means Other than Sale, Spinoff | Spin-Off of Atleos                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   242 259 229         488 730      
Cost of products   196 205 187         392 588      
Service                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   660 650 630         1,280 1,940 2,591 2,519 2,516
Cost of products   438 418 419         837 1,274 $ 1,758 $ 1,664 $ 1,735
Service | As reported                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   1,457 1,410 1,370         2,780 4,237      
Cost of products   925 970 969         1,939 2,864      
Service | Revision of Prior Period, Adjustment                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   0 0 0         0 0      
Cost of products   1 0 0         0 1      
Service | Discontinued Operations, Disposed of by Means Other than Sale, Spinoff | Spin-Off of Atleos                          
Condensed Financial Information Disclosure [Line Items]                          
Revenue   797 760 740         1,500 2,297      
Cost of products   $ 488 $ 552 $ 550         $ 1,102 $ 1,591